Stay updated on OptiPOM: Alternate Day Pomalidomide in Refractory MM Clinical Trial

Sign up to get notified when there's something new on the OptiPOM: Alternate Day Pomalidomide in Refractory MM Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the OptiPOM: Alternate Day Pomalidomide in Refractory MM Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    Summary of changes: added a government funding notice with current operating status guidance and updated version to v3.2.0; removed the old version label v3.1.0.
    Difference
    12%
    Check dated 2025-10-05T06:57:18.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    Version bump from v3.0.2 to v3.1.0; no other content changes detected.
    Difference
    0.3%
    Check dated 2025-09-28T02:53:55.000Z thumbnail image
  5. Check
    37 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.0.2 (replacing v3.0.1), and the Back to Top element has been removed.
    Difference
    0.7%
    Check dated 2025-09-13T17:17:01.000Z thumbnail image
  6. Check
    44 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or other important elements.
    Difference
    0.7%
    Check dated 2025-09-06T14:46:50.000Z thumbnail image
  7. Check
    51 days ago
    Change Detected
    Summary
    The web page has undergone significant updates, including the addition of a facility name and location, while several location-related terms have been removed.
    Difference
    17%
    Check dated 2025-08-30T11:31:45.000Z thumbnail image
  8. Check
    66 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.11 to version 2.16.12, indicating a revision in the content.
    Difference
    0.3%
    Check dated 2025-08-16T04:33:12.000Z thumbnail image

Stay in the know with updates to OptiPOM: Alternate Day Pomalidomide in Refractory MM Clinical Trial

Enter your email address, and we'll notify you when there's something new on the OptiPOM: Alternate Day Pomalidomide in Refractory MM Clinical Trial page.